Certolizumab pegol for the treatment of axial spondyloarthritis: 4-year outcomes from the RAPID-axSpA trial

M. Breban, D. Van Der Heijde, M. Dougados, R. Landewé, J. Sieper, W. Maksymowych, M. Rudwaleit, F. Van den bosch, J. Braun, P. J. Mease, O. Davies, B. HŒpken, L. Peterson, A. Deodhar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)A226-A227
JournalRevue du Rhumatisme (Edition Francaise)
Volume83
DOIs
StatePublished - Nov 1 2016

ASJC Scopus subject areas

  • Rheumatology

Cite this